MSI-H/dMMR and cancer immunotherapy: current state and future implications

被引：2
|
作者：
Rizzo, Alessandro [1 ,2 ]
Ricci, Angela Dalia [1 ,2 ]
Gadaleta-Caldarola, Gennaro [2 ]
机构：
[1] IRCCS Azienda Osped Univ Bologna, Med Oncol, Bologna, Italy
[2] Mons R Dimiccoli Hosp, Med Oncol Unit, Barletta, Italy
来源：
EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT | 2021年 / 6卷 / 06期
关键词：
MSI; dMMR; mismatch repair; cancer; immunotherapy; immune checkpoint inhibitors; MICROSATELLITE INSTABILITY;
D O I：
10.1080/23808993.2021.1946391
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：345 / 347
页数：3
相关论文
共 50 条
  • [1] Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer
    Qi Zhang
    Jian Li
    Lin Shen
    Yongsheng Li
    Xicheng Wang
    [J]. Cancer Biology & Medicine, 2023, 20 (10) : 706 - 712
  • [2] Immunotherapy Promising for Metastatic MSI-H/dMMR Colorectal Cancer
    Yarden, Ronit
    [J]. ONCOLOGY-NEW YORK, 2019, 33 (05): : 179 - 179
  • [3] Opportunities and challenges of immunotherapy for dMMR/ MSI-H colorectal cancer
    Zhang, Qi
    Li, Jian
    Shen, Lin
    Li, Yongsheng
    Wang, Xicheng
    [J]. CANCER BIOLOGY & MEDICINE, 2023, 20 (10) : 706 - 712
  • [4] Opportunities and challenges of immunotherapy for dMMR/MSI-H colorectal cancer
    Qi Zhang
    Jian Li
    Lin Shen
    Yongsheng Li
    Xicheng Wang
    [J]. Cancer Biology & Medicine, 2023, (10) : 706 - 712
  • [5] Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
    Margalit, Ofer
    Stemmer, Amos
    Chapin, William J.
    Shacham-Shmueli, Einat
    Kopetz, Scott
    Andre, Thierry
    Overman, Michael J.
    Pietrantonio, Filippo
    Boursi, Ben
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 212
  • [6] Neoadjuvant immunotherapy for dMMR/MSI-H locally advanced rectal cancer: The future new standard approach?
    Cabezon-Gutierrez, Luis
    Custodio-Cabello, Sara
    Palka-Kotlowska, Magda
    Diaz-Perez, David
    Mateos-Dominguez, Maria
    Galindo-Jara, Pablo
    [J]. EJSO, 2023, 49 (02): : 323 - 328
  • [7] Nonoperative Management of dMMR/MSI-H Colorectal Cancer following Neoadjuvant Immunotherapy: A Narrative Review
    Xiao, Binyi
    Yu, Jiehai
    Ding, Pei-Rong
    [J]. CLINICS IN COLON AND RECTAL SURGERY, 2023, 36 (06) : 378 - 384
  • [8] Genomic alteration of Chinese dMMR/MSI-H gastric cancer
    Wei, Jia
    Wang, Jian
    Fan, Xiangshan
    Wang, Yue
    Fu, Yao
    Wang, Kai
    Wu, Nandie
    Liu, Qin
    Yang, Yang
    Wang, Weifeng
    Liu, Baorui
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [9] Molecular Subtyping of dMMR/MSI-H Tumors
    Sorscher, Steven
    [J]. JCO PRECISION ONCOLOGY, 2017, 1
  • [10] Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy
    Wu, Hui
    Ma, Wenyuan
    Jiang, Congfa
    Li, Ning
    Xu, Xin
    Ding, Yongfeng
    Jiang, Haiping
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (13) : 8572 - 8587
12345